Events

Past Event

Adult Psychopharmacology Series Session 2: Psychopharmacology for Depressive Disorders, Anxiety Disorders and Obsessive-Compulsive and Related Disorders

February 9, 2021
9:30 AM - 11:30 AM
Online Live Event

$60 with 2 Live- Online CE hours provided. See registration page for all CE and discount information 

 

Series Description

As a non-prescribing clinician, you are uniquely situated to assess, monitor, and support the effectiveness of your patients’ medication treatment while advocating for your patients to receive the best care. Your success in doing so is dependent upon a strong understanding of foundational psychopharmacology, as well as the current institutional challenges within psychiatry and medicine that have come to shape disparate outcomes facing minoritized and marginalized individuals. This knowledge equips you to be a well-informed collaborator with prescribers and transform your advocacy.

At the end of this series, you will better understand basic drug concepts (including drug metabolism and mechanisms of action), indications and rationales behind prescribed medication treatments, expected and possible responses to treatment including both common and rare side effects as well as limitations within the field. The live webinars will make use of polls, case presentations by the presenter, and Q&A discussion to engage attendees in conceptualizing the information and its application.

This series will emphasize the foundational importance of shared decision making, supporting patient autonomy, and understanding the impact of power, race, oppression, and privilege on their care.

Session 2 Description and Objectives

Psychopharmacology for Depressive Disorders, Anxiety Disorders and Obsessive-Compulsive and Related Disorders

The Role of Medications in Treatments of Specific Disorders. These sessions will take a close look at the specific evidence-based psychopharmacological treatments for specific disorders. Lectures will cover mechanisms of action, dosing and side effects (common and rare) as well as approaches to treatment-resistant disorders. Dr. Coombs will also discuss regulations for use including distinctions between FDA approval and off label uses, if a substance is controlled and why and medication contraindications.

By attending each of these sessions you will better:

  • Understand the evidence-base for psychopharmacological treatments of specific disorders
  • Understand the common as well as rare and serious side effects of specific drug classes
  • Understanding approaches to failed medication trials and treatment resistance

 

Presenter:

Dr. Angela Coombs

 

Please see registration page for ALL event information including how to access the event, CE details, and special accommodations.

 

Contact Information

Office of Professional Excellence